Research programme: sphingosine-1 phosphate receptor agonists - Almirall

Drug Profile

Research programme: sphingosine-1 phosphate receptor agonists - Almirall

Alternative Names: LAS 189913

Latest Information Update: 24 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Almirall S.A.
  • Class
  • Mechanism of Action Sphingosine 1 phosphate receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Multiple sclerosis

Most Recent Events

  • 27 Jun 2014 No development reported - Preclinical for Multiple sclerosis in Europe (unspecified route)
  • 01 Feb 2012 Discontinued - Preclinical for Multiple sclerosis in Europe (unspecified route)
  • 26 Aug 2010 Pharmacodynamics and pharmacokinetics data from a preclinical trial in Multiple sclerosis presented at the 240th American Chemical Society National Meeting (240th-ACS-2010) ,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top